Status:
COMPLETED
Educational Intervention to Adopt SLT as First-Line Glaucoma Treatment
Lead Sponsor:
Wills Eye
Conditions:
Primary Open-angle Glaucoma
Eligibility:
All Genders
40-90 years
Phase:
NA
Brief Summary
The purpose of this study is to develop an educational program that will help improve the patients' understanding of what laser treatment is, how it might be beneficial to them, and why it should be t...
Detailed Description
Glaucoma is a disease characterized by optic nerve damage, visual field defects, elevated intraocular pressure (IOP) and progressive vision loss. More than 3 million Americans have glaucoma and more t...
Eligibility Criteria
Inclusion
- patients between 40 and 90 years of age
- high-risk ocular hypertension, primary open-angle glaucoma, or pseudo-exfoliation glaucoma
- currently treated with at least one glaucoma eye drop with stable intraocular pressure
Exclusion
- previous laser trabeculoplasty
- previous glaucoma surgery
Key Trial Info
Start Date :
October 23 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2019
Estimated Enrollment :
86 Patients enrolled
Trial Details
Trial ID
NCT03365778
Start Date
October 23 2017
End Date
December 31 2019
Last Update
January 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wills Eye Hospital
Philadelphia, Pennsylvania, United States, 19120